Dow Chemical Company (The) (DOW) Rating Reiterated by Jefferies Group LLC

The Dow Chemical Company has 1.22 billion shares outstanding, and in the last trade has seen ATR around 0.82. The Fagan Associates Inc holds 53,795 shares with $3.08M value, up from 46,582 last quarter. The Dow Chemical Company (DOW) has a market cap of $79.17 billion and over the last 12 months, The Dow Chemical Company (NYSE:DOW) has gone stronger by 20.21%. (NASDAQ:SHOR) traded down 0% in the last session while performance was up 7.5% in the last five days. It has outperformed by 4.02% the S&P500. The company now has an average volume of 4.93 Million. The Firm operates through ophthalmology segment.

The Average Earnings Estimate for the Current Fiscal quarter is $0.93 per share, according to consensus of 17 analysts. The Company’s ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration.

Investors sentiment increased to 1.09 in Q4 2016.

The (Simple Month Average) SMA20 is at 1.6 percent, its SMA50 Value is 0.69% and SMA200 value is reported as 5.39 Percent.

Large investors have recently bought and sold shares of the stock. 128 funds opened positions while 459 raised stakes. The Dow Chemical Company earnings have risen with an annualized rate of 11.5% over the last 5 years. Paloma Management Co invested in 0.03% or 46,100 shares. First Western Capital Management Co, a California-based fund reported 10,000 shares. Moreover, City Holding Co has 0.01% invested in the company for 1,292 shares. Henderson Grp Inc Public Ltd reported 148,877 shares. The Florida-based Thomas J. Herzfeld Advisors Inc. has invested 0.18% in the stock. 216 were accumulated by Jnba Financial Advisors. Wexford Capital Lp accumulated 142,387 shares. Chevy Chase Trust Hldgs Incorporated has invested 0.4% in Dow Chemical Co (NYSE:DOW). Autus Asset Management Limited Com owns 4,200 shares. Howe & Rusling has invested 2.45% in Dow Chemical Co (NYSE:DOW). 30,500 are owned by Grantham Mayo Van Otterloo Co Ltd Liability Co. Klingenstein Fields Limited reported 0.12% stake. Baxter Bros Inc holds 5,890 shares. It also reduced Apple Inc Com (NASDAQ:AAPL) stake by 2,931 shares and now owns 608,996 shares. Cvs Health Corp Com (NYSE:CVS) was reduced too.

Zacks presents analysts with an ABR (Average Broker Rating), based on the sell-side recommendations. Therefore 63% are positive. Finally, Royal Bank Of Canada reissued a “buy” rating and issued a $76.00 price target on shares of Dow Chemical Company (The) in a report on Thursday, July 6th. Jefferies maintained the shares of DOW in report on Monday, May 2 with “Hold” rating. On Monday, April 18 the stock rating was maintained by Citigroup with “Neutral”. Credit Suisse reinitiated it with “Outperform” rating and $56 target in Thursday, March 24 report. Jefferies Group LLC reiterated a “buy” rating on shares of Dow Chemical Company (The) in a research report on Tuesday. The firm has “Buy” rating given on Thursday, August 20 by Deutsche Bank. The firm has “Top Pick” rating by RBC Capital Markets given on Monday, December 19. The stock now has a consensus rating of “Buy” and an average target price of $71.42.

Paragon Associates & Paragon Associates Ii Joint Venture holds 23.37% of its portfolio in IRIDEX Corporation for 1.25 million shares. Cue Financial Group Inc. owns 38,553 shares or 0.41% of their United States portfolio. The other 0 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it.

Leave a Reply

Your email address will not be published. Required fields are marked *